Proarrhythmia of Azimilide and Other Class III Antiarrhythmic Agents in the Adrenergically Stimulated Rabbit
- 18 July 2008
- journal article
- Published by Wiley in Proceedings of the Society for Experimental Biology and Medicine
- Vol. 223 (2) , 183-189
- https://doi.org/10.1111/j.1525-1373.2000.22325.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Pharmacology of Azimilide Dihydrochloride (NE‐10064), A Class III Antiarrhythmic AgentCardiovascular Drug Reviews, 1997
- Suppression of Inducible Ventricular Arrhythmias by Intravenous Azimilide in Dogs with Previous Myocardial InfarctionJournal of Cardiovascular Pharmacology, 1996
- Efficacy of the Class III Antiarrhythmic Agent Azimilide in Rodent Models of Ventricular ArrhythmiaExperimental Biology and Medicine, 1996
- Extracellular Potassium Modulation of Drug Block of I KrCirculation, 1996
- Use-Dependent Effects of the Class III Antiarrhythmic Agent NE-10064 (Azimilide) on Cardiac RepolarizationJournal of Cardiovascular Pharmacology, 1995
- Comparison of the Cardiac Electrophysiologic Effects of NE-10064 with Sotalol and E-4031 and Their Modification by Simulated IschaemiaJournal of Cardiovascular Pharmacology, 1994
- Protection Against Programmed Electrical Stimulation-Induced Ventricular Tachycardia and Sudden Cardiac Death by NE-10064, a Class III Antiarrhythmic DrugJournal of Cardiovascular Pharmacology, 1993
- Early after-depolarizations and torsade de pointes: Implications for the control of cardiac arrhythmias by prolonging repolarizationEuropean Heart Journal, 1993
- QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the RabbitJournal of Cardiovascular Pharmacology, 1990
- Arrhythmogenic effects of antiarrhythmic drugs: A study of 506 patients treated for ventricular tachycardia or fibrillationJournal of the American College of Cardiology, 1989